AlphaNavi Pharma Inc.
PrivateLast Round
Series B
Mar 1, 2023
Est. Valuation
$21.19M
Total Funding Raised
$12.65M
Company Overview
AlphaNavi Pharma Inc. operates in Healthcare & Life Sciences and is based in Suita. Its latest recorded funding round was a Series B round in March 2023.
AlphaNavi Pharma Inc. is a biopharmaceutical company that develops novel non-opioid analgesic drugs for patients suffering from pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AlphaNavi Pharma Inc. Comparables
Compare AlphaNavi Pharma Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Latigo Biotherapeutics | 82% | |
| Guangzhou Fermion Technology Co., Ltd. | 80% | |
| Eli Lilly and Company | 79% |
For institutional investors. Book with your work email.
AlphaNavi Pharma Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 1, 2023 | ||||
| Series A | Mar 28, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AlphaNavi Pharma Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chushin Venture Capital | Series A, Series B |
| Shinsei Capital Partners | Series A, Series B |
| 日本ベンチャーキャピタル株式会社 | Series A, Series B |
| Kyoto University Innovation Capital | Series A, Series B |
| SMBC Venture Capital | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2026
Monthly visitors grew 91% MoM.
- Jul 6, 2025
Monthly visitors increased 38% MoM.
For institutional investors. Book with your work email.
AlphaNavi Pharma Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AlphaNavi Pharma Inc.'s valuation, stock price, and market status.
Is AlphaNavi Pharma Inc. a public or private company?
AlphaNavi Pharma Inc. is a private company.
What is the current stock price of AlphaNavi Pharma Inc.?
AlphaNavi Pharma Inc. is a private company, so its shares have no public market price. Caplight tracks AlphaNavi Pharma Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AlphaNavi Pharma Inc. worth (valuation)?
AlphaNavi Pharma Inc.'s valuation is estimated at $21.2M based on funding round data.
Can I buy AlphaNavi Pharma Inc. stock?
AlphaNavi Pharma Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AlphaNavi Pharma Inc.'s last funding round?
AlphaNavi Pharma Inc.'s most recent funding round was Series B on March 1, 2023.
Who are the main investors in AlphaNavi Pharma Inc.?
Key investors in AlphaNavi Pharma Inc. include Chushin Venture Capital, Shinsei Capital Partners, 日本ベンチャーキャピタル株式会社, Kyoto University Innovation Capital, SMBC Venture Capital.
Will AlphaNavi Pharma Inc. IPO soon?
No public IPO plans have been announced for AlphaNavi Pharma Inc..
How can I track AlphaNavi Pharma Inc. secondary market activity?
Caplight tracks bids, offers, and trades in AlphaNavi Pharma Inc.'s shares on secondary markets.